OUP accepted manuscript
01 Jan 2022
About: This article is published in European Heart Journal Supplements. The article was published on 01 Jan 2022. and is currently open access. The article focuses on the topics: Medicine.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
Gerhard Hindricks,Tatjana S. Potpara,Nikolaos Dagres,Elena Arbelo,Jeroen J. Bax,Carina Blomström-Lundqvist,Giuseppe Boriani,Manuel Castellá,Gheorghe Andrei Dan,Polychronis Dilaveris,Laurent Fauchier,Gerasimos Filippatos,Jonathan M. Kalman,Jonathan M. Kalman,Mark La Meir,Deirdre A. Lane,Jean-Pierre Lebeau,Maddalena Lettino,G. Y. H. Lip,Fausto J. Pinto,G. Neil Thomas,Marco Valgimigli,Isabelle C. Van Gelder,Isabelle C. Van Gelder,Bart P. Van Putte,Caroline L Watkins +25 more
TL;DR: The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only and no commercial use is authorized.
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
Scott D. Corley,Andrew E. Epstein,John P. DiMarco,Michael J. Domanski,Nancy L. Geller,H. Leon Greene,Richard Josephson,Joyce C Kellen,Richard C. Klein,Andrew D. Krahn,Mary Mickel,L. Brent Mitchell,Joy Dalquist Nelson,Yves Rosenberg,Eleanor Schron,Lynn Shemanski,Albert L. Waldo,D. George Wyse,Affirm Investigators +18 more
TL;DR: An “on-treatment” analysis of the relationship of survival to cardiac rhythm and treatment as they changed over time suggests that any beneficial antiarrhythmic effects of AADs are offset by their adverse effects.
1.3K
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Andreas Goette,Jonathan M. Kalman,Luis Aguinaga,Joseph G. Akar,José Angel Cabrera,Shih Ann Chen,Sumeet S. Chugh,Domenico Corradi,Andre d'Avila,Dobromir Dobrev,Guilherme Fenelon,Mario D. Gonzalez,Stéphane N. Hatem,Robert H. Helm,Gerhard Hindricks,Siew Yen Ho,Brian Hoit,José Jalife,Young Hoon Kim,Gregory Y.H. Lip,Chang Sheng Ma,Gregory M. Marcus,Katherine T. Murray,Akihiko Nogami,Prashanthan Sanders,William Uribe,David R. Van Wagoner,Stanley Nattel,Stanley Nattel +28 more
TL;DR: The working group proposes the following working definition of atrial cardiomyopathy: ‘Any complex of structural, architectural, contractile or electrophysiological changes affecting the atria with the potential to produce clinically-relevant manifestations’ (Table 1).
698
Atrial Cardiomyopathy: A Useful Notion in Cardiac Disease Management or a Passing Fad?
J.B. Guichard,Stanley Nattel +1 more
TL;DR: The authors consider critically the added clinical value of this concept and its meaningfulness, and discuss how atrial cardiomyopathic properties might guide stroke prevention, rhythm maintenance, and rate control in atrial fibrillation.
191
Changing the Paradigm to Understand and Manage Atrial Fibrillation
Gheorghe-Andrei Dan
- 01 Jan 2014
TL;DR: A better understanding of the complex mechanisms for AF initiation and perpetuation helps to change the management paradigm and to understand better the targets of the future therapy aimed to restore and maintain the sinus rhythm with the expected long-term consequences on outcome.
7